News & Updates

The hemostatic powder TC-325 has demonstrated its noninferiority to standard treatment in the endoscopic control of bleeding from nonvariceal upper gastrointestinal causes, reports a study.

In a subgroup analysis of the phase IV FIRST trial presented at ASH 2021, the oral iron chelator deferiprone was comparable to the infusion-administered deferoxamine in terms of efficacy and safety in iron-overloaded children receiving chronic transfusion therapy for sickle cell disease (SCD) and other anaemias.

The Timed Up-and-Go (TUG) test is a strong predictor of long-term mortality in community-dwelling older adults, outperforming other physical and functional measures, according to a Singapore study.

The platelet-to-lymphocyte ratio (PLR) might be a potential indicator of in-hospital mortality in patients admitted to the cardiac intensive care unit (CICU), a recent study has found.

While there are no differences in COVID-19-related outcomes in patients with inflammatory bowel disease (IBD) between those in remission vs those who are not, being on medications such as corticosteroids and aminosalicylates may put them at higher risk of hospitalization, suggest studies presented at AIBD 2021.